Celebrex
Millions of Americans take Celebrex for arthritis or other pain. Many, if they are middle-aged or older, also take a low-dose aspirin tablet daily to reduce the risk of heart attack and stroke. Yet they may be getting little protection, because Celebrex keeps the aspirin from doing its job effectively, a new study suggests.
In laboratory studies, University of Michigan researchers found that several coxibs, the drug class to which Celebrex belongs, interfere with aspirin's ability to discourage blood clots, if the aspirin is taken in low doses. Celebrex, also known as celecoxib, is the only coxib currently on the market. The results appear online in the Proceedings of the National Academy of Sciences.
Doctors frequently advise daily low-dose aspirin (81 mg) for patients who have heart conditions, notably a serious form of angina known as unstable angina, or for patients who are at risk of second heart attacks. Aspirin is well-known for its ability to discourage formation of blood clots that can lead to heart attack and stroke. In addition, arthritis patients who take Celebrex regularly are often put on low-dose aspirin because this is thought to counteract Celebrex's own potential clot-promoting effect.
"There are many people who take low-dose aspirin, perhaps as many as half of men over 50. If they are also prescribed Celebrex for arthritis or other pain, our results suggest that the Celebrex will probably interfere with the aspirin's action," says William L. Smith, Ph.D., the study's senior author, Minor J. Coon Professor of Biological Chemistry and chair of the biochemistry department at the U-M Medical School.
"The greatest risk is having people take Celebrex who are taking aspirin for cardiovascular problems that are known to be mitigated by aspirin, including patients with unstable angina or those at risk for a second heart attack," he says. In unstable angina, small clots form in arteries and interfere with blood flow.
Previous studies of healthy subjects found no ill effect on blood clotting when Celebrex was combined with aspirin at higher doses, specifically a daily "regular" aspirin tablet (324 mg), Smith notes.
So it may be that a higher aspirin dose, or spreading out the time between taking low-dose aspirin and Celebrex, will allow aspirin to be effective. Aspirin's undesirable effects on the gastrointestinal tract at higher doses when taken long-term would have to be taken into account.
First, though, the effect seen in the U-M study needs to be replicated in studies of low-dose aspirin and Celebrex in people, perhaps in older patients who have conditions such as rheumatoid arthritis, says Smith. If the effect holds true in people, it will be important to determine if a balance in dose and/or dose regimens can be found so that aspirin and Celebrex can both be effective.
Research details
The researchers used biochemical measurements and X-ray crystallography to discover that celecoxib binds to COX-1, an enzyme that promotes clotting, and slows aspirin's COX-1-blocking action. In animal studies, the researchers found more clumping of platelets – the initial stage of clotting – in blood from animals given Celebrex and low-dose aspirin than in animals given only low-dose aspirin.
###
University of Michigan Health System: http://www.med.umich.edu Thanks to University of Michigan Health System for this article.
This article has been viewed 430 time(s).
 |
 Digg |
 FarkIt |
 |
 StumbleUpon |
 del.icio.us |
 |
UCLA scientists have identified for the first time a cell-of-origin for human prostate cancer, a discovery that could result in better predictive and diagnostics tools and the development of new and more effective targeted treatments for the disease.
In Greek mythology, the gods punished Sisyphus by condemning him to roll a rock up a steep hill for eternity. But he was probably better off than if they'd condemned him to sit and stare into space until the end of time, conclude the authors of a new study on keeping busy. They found that people who have something to do, even something pointless, are happier than people who sit idly.
Public immunization efforts may be much more sensitive than previously realized to small changes in the perceived costs or risks of vaccination, scientists at Harvard University report this week. In some cases, the spread of vaccine avoidance via social networks can make the difference between a minor, localized outbreak and an epidemic four times as large.
A new study from Perth's Telethon Institute for Child Health Research shows an association between ADHD and a 'Western-style' diet in adolescents.
Stronger suction is required to smoke "electronic cigarettes" – marketed as tobacco-free nicotine delivery systems – than conventional brands, with possible adverse effects on human health, researchers at the University of California, Riverside report.
Obese older adults are more likely to use walkers, canes and other mobility devices at a younger age, and may run the risk of using them incorrectly, according to new research from Purdue University.
Heterosexual women bear the brunt of narcissistic heterosexual men's hostility, while heterosexual men, gay men and lesbian women provoke a softer reaction, according to psychologist Dr. Scott Keiller from Kent State University at Tuscarawas in the US. This is likely to be due to women's unparalleled potential for gratifying, or frustrating, men's narcissism. They are crucial players and even gatekeepers in men's quests for sexual pleasure, patriarchal power and status. Dr. Keiller's findings are published online in Springer's journal Sex Roles.
Current research suggests that taking morphine can block new blood vessel and tumor growth. The related report by Koodie et al, "Morphine suppresses tumor angiogenesis through a HIF1α/p38MAPK pathway," appears in the August 2010 issue of the American Journal of Pathology.